Izotropic Corporation (IZO.CN)

CAD 0.04

(-20.0%)

Operating Expenses Summary of Izotropic Corporation

Izotropic Corporation's latest annual operating expenses in 2023 was 1.56 Million CAD , down -70.64% from previous year.
Izotropic Corporation's latest quarterly operating expenses in 2024 Q1 was 270.02 Thousand CAD , down -20.23% from previous quarter.
Izotropic Corporation reported a annual operating expenses of 5.33 Million CAD in annual operating expenses 2022, down -19.61% from previous year.
Izotropic Corporation reported a annual operating expenses of 6.63 Million CAD in annual operating expenses 2021, up 33.34% from previous year.
Izotropic Corporation reported a quarterly operating expenses of 230.53 Thousand CAD for 2023 Q3, down -66.45% from previous quarter.
Izotropic Corporation reported a quarterly operating expenses of 1.64 Million CAD for 2023 FY, down -69.25% from previous quarter.

Annual Operating Expenses Chart of Izotropic Corporation (2023 - 2016)

Historical Annual Operating Expenses of Izotropic Corporation (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	1.56 Million CAD	-70.64%
2022	5.33 Million CAD	-19.61%
2021	6.63 Million CAD	33.34%
2020	4.97 Million CAD	330.52%
2019	1.15 Million CAD	190.02%
2018	398.53 Thousand CAD	-43.5%
2017	705.4 Thousand CAD	870.45%
2016	72.68 Thousand CAD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	270.02 Thousand CAD	-20.23%
2023 Q3	230.53 Thousand CAD	-66.45%
2023 FY	1.64 Million CAD	-69.25%
2023 Q1	429.37 Thousand CAD	-63.58%
2023 Q2	687.1 Thousand CAD	60.02%
2023 Q4	322.75 Thousand CAD	40.0%
2022 Q2	1.29 Million CAD	34.15%
2022 Q1	964.27 Thousand CAD	-40.58%
2022 FY	5.33 Million CAD	-19.61%
2022 Q4	1.17 Million CAD	-38.51%
2022 Q3	1.91 Million CAD	48.22%
2021 Q2	2.55 Million CAD	108.74%
2021 Q3	1.23 Million CAD	-51.81%
2021 Q4	1.62 Million CAD	31.74%
2021 FY	6.63 Million CAD	33.34%
2021 Q1	1.22 Million CAD	-35.73%
2020 Q2	371.31 Thousand CAD	-17.27%
2020 FY	4.97 Million CAD	330.52%
2020 Q4	1.9 Million CAD	-15.35%
2020 Q3	2.25 Million CAD	506.13%
2020 Q1	448.81 Thousand CAD	-25.83%
2019 Q2	155.38 Thousand CAD	6.12%
2019 FY	1.15 Million CAD	190.02%
2019 Q4	605.14 Thousand CAD	143.13%
2019 Q1	146.42 Thousand CAD	5.64%
2019 Q3	248.89 Thousand CAD	60.18%
2018 Q2	94.39 Thousand CAD	7.37%
2018 Q3	77.62 Thousand CAD	-17.76%
2018 Q4	138.6 Thousand CAD	78.55%
2018 FY	398.53 Thousand CAD	-43.5%
2018 Q1	87.91 Thousand CAD	-43.32%
2017 Q3	68.98 Thousand CAD	-83.14%
2017 Q4	155.11 Thousand CAD	124.85%
2017 FY	705.4 Thousand CAD	870.45%
2017 Q1	72.07 Thousand CAD	99.09%
2017 Q2	409.22 Thousand CAD	467.76%
2016 Q2	22.1 Thousand CAD	49.03%
2016 Q1	14.83 Thousand CAD	0.0%
2016 Q4	36.2 Thousand CAD	138.03%
2016 FY	72.68 Thousand CAD	0.0%
2016 Q3	15.21 Thousand CAD	-31.19%

Peer Operating Expenses Comparison of Izotropic Corporation

Name	Operating Expenses	Operating Expenses Difference
BioMark Diagnostics Inc.	1.47 Million CAD	-5.911%
Sona Nanotech Inc.	2.43 Million CAD	35.578%